Anacor's boron-based drug stops the rot
An unusual drug that contains a crucial boron atom can effectively treat fungal infections, and could also prove invaluable in the effort to counter antibacterial drug resistance.
Archives for June 24, 2007
Viracept saga continues
In the latest episode of the Viracept contamination case, the drug is now at risk of losing its marketing authorisation across Europe while the dangers posed by the chemical contaminant are established and manufacturer Roche rectifies its...
Parexel talks Tegenero and Phase I future
Parexel talks to Outsourcing-Pharma about Phase I trials, touching on trends and growth opportunities, future plans for India and lessons learned from Tegenero.
Genzyme pens deal for Parkinson's gene therapy
Genzyme has put pen to paper on a licensing deal for Ceregene's Parkinson's drug, as a rival gene therapy for the same disease shows promise in initial clinical trials.
Roche signs $370m deal for Phase I arthritis drug
Roche has committed hundreds of millions of dollars to an early-phase rheumatoid arthritis drug, a move that is indicative of big pharma's increasing tendency to license earlier phase compounds.
Microtest, Texcel combine for 'combo drugs'
Microtest Laboratories and Texcel Medical have teamed up to offer biopharma firms services to help them overcome the hurdles of developing "combination products" - a fast-growing market.
Third Chinese drug official charged in corruption scandal
China's resolve to clean up corruption in its pharma industry has intensified as the former assistant to the already-condemned-to-death former drug chief has now been charged.